Philip Morris Accused of Misleading Consumers with Nicotine Content in Iqos Product Series

Aug.29.2022
Philip Morris Accused of Misleading Consumers with Nicotine Content in Iqos Product Series
Philip Morris International is accused of misleading consumers about the nicotine content of its IQOS heated tobacco products.

The world's largest multinational tobacco company, Philip Morris International, is facing allegations of deceiving consumers about the nicotine content in its Iqos heated tobacco product series.


The product is a supposed "better" alternative to cigarettes developed by the company. In its marketing, the Philippine National Tobacco Company claims that each cigarette contains 0.5 milligrams of nicotine. However, recent research shows that the actual nicotine content of the product is more than eight times higher.


Currently, there is no international standard for testing the content of heated tobacco products, leaving a gray area in determining how to obtain and disclose this information to consumers.


Heated tobacco products are becoming increasingly popular, accounting for over 2.5% of all tobacco sales in the European Union. These devices heat disposable tobacco sticks without combustion, unlike vaping or e-cigarettes, which typically contain nicotine but not tobacco. Last year, PMI estimated that its heated tobacco line has approximately 20 million users.


The test was conducted by Unisanté, the Swiss University Center for General Medicine and Public Health, and analyzed by Force Technology in Denmark. The results showed that each disposable cigarette contains 4.1 milligrams of nicotine. Nicotine, like heroin and cocaine, is one of the most addictive drugs in the world and the reason why people become addicted to tobacco, which causes over 8 million deaths annually.


The 0.5 milligrams figure from PMI appears to come from a revised version of their own international standard organization (ISO) testing regime. The ISO system measures the amount of nicotine emitted in cigarette smoke that you inhale, which is often significantly lower than the total amount of nicotine in the cigarette.


However, even though the 0.5 milligrams referred to the emissions from the cigarette filter, the agency's testing revealed that each cigarette actually emits more than twice that amount, at 1.2 milligrams. When contacted by the agency, PMI stated that they had discovered a similar number in their own “intense smoking regime” testing, but there is no evidence that they had ever used this number in any public communications.


PMI has accused the agency of conflating nicotine emissions with the amount of nicotine present in tobacco products. In addition, it has stated that its own testing has found that each cigarette contains up to 4.6mg of total nicotine, making these products "as addictive as cigarettes.


The company also stated that the nicotine content in heated tobacco sticks and cigarettes is "low in correlation to consumers," and pointed out the differences between nicotine content, emissions, and exposure (the amount absorbed by the user).


However, without clear universal regulations on which numbers to use and how to describe them, consumers will continue to be misled.


Utilizing gray areas. (Note: This phrase appears to be incomplete and lacks context.)


For years, testing and quantifying the nicotine content of their products has been a critical area of interest for large tobacco companies seeking to exploit regulatory loopholes for their own profit.


The ISO testing method, favored by the European Union and utilized by PMI, has received harsh criticism from scientists for underestimating actual smoking behaviors. Researchers suggest that the method is "not sufficient for product regulation or consumer information." The testing conducted by the agency utilized Canada's intensive health department system, which is an alternative testing method verified and recommended by the World Health Organization (WHO).


Almost 20 years ago, the World Health Organization cautioned that calculating the amounts of nicotine in cigarettes using the ISO method was misleading. Its Tobacco Control Framework Convention states that "the yields of tar, nicotine and other smoke constituents generated from smoking machines do not provide an effective estimate of human exposure.


Therefore, according to guidelines from the World Health Organization, numbers related to emissions, including nicotine and tar, should not be displayed on packaging. EU law also prohibits the promotion of any information regarding nicotine content on tobacco product labels. While PMI may not be breaking any laws regarding packaging, they continue to promote the misleading 0.5mg nicotine figure for their Iqos product worldwide, including on the company's Swiss website and only recently removing it from their UK website.


The bureau also conducted real-time web chats with the company on its websites in South Africa, Malaysia, and European countries, inquiring about the nicotine content of their disposable cigarette buds.


When responding, employees from 11 countries cited the number 0.5 milligrams, but only two of those countries clarified that it referred to nicotine levels in the emissions, while the other nine wrongly claimed or implied it referred to the amount of nicotine in the actual tobacco stick. At one point, an employee on PMI Sweden's website claimed that the nicotine content in the heated tobacco sticks, marketed as "Heets," was 24 times higher than traditional cigarettes.


Stefania Muccifora, an Iqos user from Italy, says that she searched for the nicotine content of Heets tobacco sticks on Google and found that the PMI website indicated that they only contain 0.5 milligrams per stick. She was surprised and said, "Wow, that's 20 times less than what I'm used to smoking." As a result, she started using Iqos. Staff at an Iqos store in Rome reportedly provided similar information, stating that each Heets stick contains 0.5 milligrams of nicotine. When asked if Heets sticks contain less nicotine than traditional cigarettes, they replied, "Yes, much less. For example, Marlboro Red contains 14 milligrams.


Enrico Davoli, a tobacco expert from the Mario Negri Pharmacological Research Institute in Milan, has stated that the agency's findings are in line with international research reviewed by the independent tobacco product regulation research group of the World Health Organization, of which he is a part. He said that PMI's claim that its tobacco sticks contain 0.5mg of nicotine is "not an accurate statement".


PMI informed the agency that regulations in certain countries require the use of the ISO system to report nicotine emissions, "therefore, in such cases, we report 0.5 milligrams.


The company initially told the station that it would not respond to an organization sponsored by a "special interest group" that writes sponsored content.


Setting standards.


Since the introduction of PMI's iQOS series eight years ago, heated tobacco has been a rapidly growing market, but the International Organization for Standardization has not yet released international standard tests for analyzing chemicals in heated tobacco products.


The committee responsible for providing standardized methods for tobacco products is composed of experts, scholars, and industry professionals from 31 countries. It is chaired by Wolf-Dieter Heller, a former tobacco industry lobbyist.


A committee member informed the chair that the names of the remaining members were confidential, but most of them were from the tobacco industry. He stated, "I know them all." When the bureau requested ISO to provide the committee member list, they were told that due to data protection and "avoiding third-party influences on members," names could not be disclosed.


According to a member, the International Organization for Standardization (ISO) holds a conference annually in various cities around the world. "Industry representatives can pay to attend the conference, but public research institutions are not able to do so.


They added that the workload is significant, and each vote that committee members must make requires extensive reading. They said this is difficult to balance with their daily academic work, which strongly supports an overly bureaucratic process that favors the tobacco industry.


Committee manager Juliane Jung stated, "The development process for many standards, especially new ones, requires time. Working groups and appropriate advisory committees will examine each topic and assess the necessity of standardization.


How easy is it to get addicted to heated tobacco?


As heating tobacco is a relatively new product, its long-term health effects are largely unknown. PMI has requested that the Italian Ministry of Health review its research on Iqos so that the company can legally claim that these products are less harmful than traditional cigarettes.


The US Food and Drug Administration had found evidence suggesting that the harmful chemicals produced by the use of Iqos were fewer than those produced by smoking. However, the Italian National Institute of Health (ISS), which represented the health department during the review, concluded that there were 80 substances present only in Iqos emissions or at concentrations far higher than in cigarettes. Four of these substances were classified as carcinogens, while eight others could potentially cause DNA damage leading to cancer or birth defects.


The report by the ISS highlighted that PMI failed to provide specific research on the level of addiction induced by Iqos, as required by Italian law for the launch of new tobacco products to the market.


Various pieces of evidence, including tests conducted by PMI itself, suggest that Iqos may be just as addictive as traditional cigarettes. Our findings indicate that although a single Iqos stick has less nicotine content than a cigarette, it emits chemical substances at twice the efficiency of a cigarette during the inhalation process. As a result, an individual's intake of nicotine is essentially the same.


In a statement provided to the agency, PMI acknowledges that "adult smokers who switch to IQOS get the same amount of nicotine as they would from cigarettes.


According to the anti-smoking center at Milan's National Cancer Institute, the high concentration of nicotine in Iqos suggests it may lead to high levels of addiction. Roberto Boffi, the center's director, stated that some patients "seem to smoke more with Iqos than with traditional cigarettes".


As PMI's own information has been proven to be misleading and inconsistent, Iqos users are unaware of how addicted they are to the product.


An Italian woman who was once a Marlboro Red smoker told officials, "I started using Iqos because I thought I would smoke less and eventually quit smoking completely." "But now that I have Iqos, I find myself smoking more.


Statement:


This article is compiled based on third-party information and is intended solely for industry communication and learning purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of the content. The translation of this article is only intended for industry exchange and research.


Due to limitations in translation ability, this article may not fully express the same meaning as the original text. Please refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS aligns completely with the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for immediate removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Product | JT Refreshes Ploom CUBE Design and Expands Japan Retail Distribution, Targeting Younger Men and Female Users
Japan Tobacco (JT) launched a refreshed Ploom CUBE design in Japan on September 8, 2026, with broader convenience-store and tobacco-retail distribution planned from October 13. The updated device retains the existing Rounded Cube form and heating platform while replacing four previous body colors with Pebble White and Cobalt Black. JT is also introducing new Front Panels and Fabric Back Covers, although the new accessories are not compatible with the previous Ploom CUBE design. The company says the update is intended to broaden appeal among younger male and female users.
Sep.09
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia’s TGA Places Nicotine Pouches Under Therapeutic Goods Rules From July 24, Blocking Imports of Unapproved Products
Australia is strengthening controls on nicotine pouches under its existing therapeutic goods regulatory framework. According to the Therapeutic Goods Administration (TGA), nicotine pouch products must meet regulatory requirements, and unapproved products cannot be legally imported. The move follows Australia’s broader approach of maintaining strict oversight of nicotine products, including nicotine-containing vapes. As nicotine pouches expand globally, Australia’s regulatory approach highlights growing differences in how countries manage emerging smoke-free nicotine products.
Regulations
Jul.27
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
Reuters Tracks Big Tobacco’s Shift Beyond Cigarettes as Nicotine Pouches Vie for the Next Growth Curve
As cigarette markets face long-term pressure, major tobacco companies are increasingly turning to nicotine pouches in search of growth beyond combustible tobacco. Reuters has examined whether nicotine pouches can become the next strategic growth platform for companies including Philip Morris International, British American Tobacco and Japan Tobacco. PMI strengthened its position through the acquisition of Swedish Match and its ZYN brand, while BAT and JTI continue expanding their own nicotine pouch portfolios. The category has gained attention because of its smoke-free, device-free format, but regulation, youth-use concerns and market scale will determine whether it can become a long-term growth engine.
Regulations
Aug.18 by 2Firsts Perspectives
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands Acquires Helwit Owner Yoik Group for SEK 515 Million, More Than Doubling Swedish Nicotine Pouch Share
Imperial Brands has agreed to acquire 100% of Swedish modern oral nicotine company Yoik Group AB for an initial SEK515 million, equivalent to about US$53.9 million, plus a deferred payment linked to performance over the next two years. Yoik owns nicotine pouch brand Helwit, which held about 3.4% of Sweden’s modern oral nicotine market over the past 12 months. Imperial says the acquisition will more than double its existing share of the Swedish market. Helwit is also sold elsewhere in the Nordics, through European online channels and in selected UK retail outlets.
Sep.08